Showing results (1091-1100 of 1,252) with videos related to
Sort By:
Pageof 126
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|December 12, 2025
Fasting urine osmolality and risk of kidney disease progression in patients with type 2 diabetesJian-Jun Liu, Sylvia Liu, Joe de Keizer, et al.Bioorganic & Medicinal Chemistry Letters|February 9, 2008
2-(1H-Imidazol-4-yl)ethanamine and 2-(1H-pyrazol-1-yl)ethanamine side chain variants of the IGF-1R inhibitor BMS-536924Mark G Saulnier, David B Frennesson, Mark D Wittman, et al.Pulmonary Medicine|April 8, 2020
Association of TERT, OGG1, and CHRNA5 Polymorphisms and the Predisposition to Lung Cancer in Eastern AlgeriaAsma Mimouni, Etienne Rouleau, Patrick Saulnier, et al.Kidney International Reports|December 19, 2024
Unraveling Diabetic Kidney Disease: The Roles of Mitochondrial Dysfunction and ImmunometabolismPhoom Narongkiatikhun, Ye Ji Choi, Hailey Hampson, et al.Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 10, 2017
White blood cell fractions correlate with lesions of diabetic kidney disease and predict loss of kidney function in Type 2 diabetesKevin M Wheelock, Pierre-Jean Saulnier, Stephanie K Tanamas, et al.The Journal of Clinical Endocrinology and Metabolism|May 13, 2025
Urine choline oxidation metabolites predict chronic kidney disease progression in patients with type 2 diabetesJian-Jun Liu, Sylvia Liu, Resham L Gurung, et al.Diabetologia|August 6, 2016
ANGPTL2 is associated with an increased risk of cardiovascular events and death in diabetic patientsBarnabas Gellen, Nathalie Thorin-Trescases, Philippe Sosner, et al.Bioorganic & Medicinal Chemistry Letters|June 24, 2008
Balancing oral exposure with Cyp3A4 inhibition in benzimidazole-based IGF-IR inhibitorsKurt Zimmermann, Mark D Wittman, Mark G Saulnier, et al.Bioorganic & Medicinal Chemistry Letters|April 20, 2010
Insulin-like growth factor-1 receptor (IGF-1R) kinase inhibitors: SAR of a series of 3-[6-(4-substituted-piperazin-1-yl)-4-methyl-1H-benzimidazol-2-yl]-1H-pyridine-2-oneUpender Velaparthi, Mark G Saulnier, Mark D Wittman, et al.Journal of the American Geriatrics Society|March 25, 2023
Nocturnal hypoglycemia is underdiagnosed in older people with insulin-treated type 2 diabetes: The HYPOAGE observational studyAnne-Sophie Boureau, Béatrice Guyomarch, Pierre Gourdy, et al.Pageof 126